Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sniper007on Jan 03, 2014 8:24pm
176 Views
Post# 22057794

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Observer saves his energy!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Observer saves his energy!ok, fair enough but this forum is a discussion board, not a means of directly impacting the sp.  That is not why we are here but if it affects the sp positively then that's great.  Percentage-wise ten cents is a lot but "if" we get a licensing deal, ten cents will make you laugh cause the sp should at minimum double imo - it would greatly surprise me if it didn't (maybe someone else can comment on that).  Other members on here have posted reasons as to why there is no action or offers, however, there may be already and we just don't know it.  Both KayakerBC and Jdstox have commented on how long deals can take with pharmas, especially when you're talking about hundreds of millions (jdstox posted this week), no small chump change.  Until all parties are satisfied with an agreement (think hundreds of millions) a press release cannot be issued.  Other licensing deals with companies with similar technology to BTI have been hundreds of millions (these have also been posted in the past on here).
Oil, if you adjust your approach/questions you might get better results from the members on here.
Bullboard Posts